Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study - Scorecard - MDSpire

Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study

  • By

  • Jiali Yang

  • Xinru Li

  • Liangqiu Tang

  • Wenmao Fan

  • Aihua Li

  • Wanming Zhou

  • Jungang Pang

  • Qiuxiao Yuan

  • Ming Zhong

  • Jinhui Hou

  • Lan Wang

  • Wenjiao Liao

  • Xiangyang Liu

  • BMC Cardiovascular

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: Correction: Impact of Dapagliflozin on Cardiorespiratory Fitness in Individuals with Coronary Heart Disease and Type 2 Diabetes Mellitus Post-PCI: A Prospective Randomized Controlled Trial at a Single Center

At a Glance

CategoryDetail
Condition
Key MechanismsDapagliflozin effects on cardiorespiratory fitness (as corrected in the original article)
Target Population
Care Setting

Key Highlights

  • Correction of ACEI medication proportion in the dapagliflozin group (as per original article)
  • Correction of nitrates proportion in the non-dapagliflozin group (as per original article)
  • Correction of BMI P-value (as per original article)
  • Updated entries in Table 6 for Adjusted OR, 95% CI, and P (as per original article)

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Individuals with coronary heart disease and type 2 diabetes post-PCI

          Dapagliflozin's impact on cardiorespiratory fitness

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study

            • by Jiali Yang, Xinru Li, Liangqiu Tang, Wenmao Fan, Aihua Li, Wanming Zhou, Jungang Pang, Qiuxiao Yuan, Ming Zhong, Jinhui Hou, Lan Wang, Wenjiao Liao, Xiangyang Liu, BMC Cardiovascular

            • June 2, 2026

            Related Content

            Influence of nursing cardiac rehabilitation on cardiac function and quality of life in patients with coronary heart disease after percutaneous coronary intervention

            Dyadic coping experiences of young and middle-aged patients undergoing PCI for coronary heart disease and their spouses during the perioperative period: a qualitative study

            Association between the C-reactive protein-triglyceride-glucose index and major adverse cardiovascular events in patients undergoing percutaneous coronary intervention